Kishore Ponnavolu - 22 Feb 2022 Form 4 Insider Report for METLIFE INC (MET)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Feb 2022, 18:57:16 UTC
Next SEC filing
03 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen W. Gauster, Authorized Signer

Key filing fact

Kishore Ponnavolu filed Form 4 for METLIFE INC (MET) on 24 Feb 2022.

Key facts

  • This page summarizes Kishore Ponnavolu's Form 4 filing for METLIFE INC (MET).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Feb 2022, 18:57.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$818,141.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MET transaction

Common Stock

Award

Transaction value
Shares
+5,003
Change %
+12%
Price
Shares after
46,102
Date
22 Feb 2022
Ownership
Direct
Footnotes
F1
MET transaction

Common Stock

Award

Transaction value
Shares
+26,582
Change %
+58%
Price
Shares after
72,684
Date
22 Feb 2022
Ownership
Direct
Footnotes
F2
MET transaction

Common Stock

Tax liability

Transaction value
$818,141
Shares
-11,864
Change %
-16%
Price
$68.96
Shares after
60,820
Date
22 Feb 2022
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MET transaction Derivative

Employee Stock Options (right to buy)

Award

Transaction value
$0
Shares
+15,007
Change %
Price
$0.000000
Shares after
15,007
Date
22 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,007
Exercise price
$68.96
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

Footnote F2

Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

Footnote F3

Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

Footnote F4

The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .